BioCentury
ARTICLE | Company News

Cleveland BioLabs, Bioprocess Capital Ventures deal

July 13, 2015 7:00 AM UTC

Cleveland sold 75% of its equity stake in Incuron for about $3 million to Dr. Mikhail Mogutov, who is the chairman of Incuron. Mogutov has an option to purchase Cleveland’s remaining stake for $1 mill...